Bruntwood, in partnership with the Greater Manchester Property Venture Fund, has been selected as preferred bidder for AstraZeneca’s 400-acre Alderley Park biochemical site.
The deal is subject to funding from GMPVF.
Telereal Trillium, Bruntwood and a private consortium set up
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
